RICHMOND, Va. — A nonprofit organization says it is planning a new pharmaceutical manufacturing plant in Petersburg that’s expected to create more than 180 new jobs and make drugs for treatment of COVID-19 and other diseases.
The Richmond Times-Dispatch reports state officials announced Thursday that Civica Inc., a nonprofit organization formed by various U.S. health care providers, plans to invest $124.5 million to establish its first in-house pharmaceutical manufacturing operation in Petersburg.
It’s to be located adjacent to an existing pharmaceuticals factory operated by AMPAC Fine Chemicals.
A key partner is a Richmond-based pharmaceutical development company, which says it received a federal contract to help build a national, strategic reserve of essential medications.
